OSE Pharma SA (OSE) — Cash Flow Reinvestment Rate
Latest as of June 2024:
0.00x
OSE Pharma SA (OSE) has a Cash Flow Reinvestment Rate of 0.00x as of June 2024, reinvesting €18.00K (capex €18.00K ) from operating cash flow of €66.63 Million. See OSE free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
€18.00K
Capex + Investments
Operating Cash Flow
€66.63 Million
EUR
Capital Expenditures
€18.00K
EUR
OSE Pharma SA Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for OSE Pharma SA across 4 annual periods. For the full cash flow conversion analysis, see OSE cash flow conversion.
Annual Cash Flow Reinvestment Rate for OSE Pharma SA (2016–2024)
Year-by-year capital reinvestment analysis for OSE Pharma SA. See OSE Pharma SA financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.97x | €46.99 Million | €48.44 Million | €77.00K | ▲ +221.0% |
| 2019 | 0.30x | €2.71 Million | €8.97 Million | €336.00K | ▼ -71.7% |
| 2018 | 1.07x | €1.15 Million | €1.08 Million | €593.00K | ▼ -88.1% |
| 2016 | 8.97x | €6.13 Million | €684.00K | €30.00K | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow